Protalix BioTherapeutics
PLX
PLX
45 hedge funds and large institutions have $8.4M invested in Protalix BioTherapeutics in 2024 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 12 increasing their positions, 8 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
2% more funds holding
Funds holding: 44 → 45 (+1)
1.32% more ownership
Funds ownership: 4.65% → 5.97% (+1.3%)
Holders
45
Holding in Top 10
–
Calls
$98K
Puts
$10K
Top Buyers
| 1 | +$1.28M | |
| 2 | +$305K | |
| 3 | +$239K | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$192K |
| 5 |
Jane Street
New York
|
+$127K |
Top Sellers
| 1 | -$243K | |
| 2 | -$73.4K | |
| 3 | -$72.2K | |
| 4 |
SA
Sanctuary Advisors
Indianapolis,
Indiana
|
-$62.7K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$35.8K |